TrialJournal of the American Heart Association2022

Laboratory Test Predictors for Major Bleeding in Elderly (≥80 Years) Patients With Nonvalvular Atrial Fibrillation Treated With Edoxaban 15 mg: Sub-Analysis of the ELDERCARE-AF Trial.

Takeshi Mikami et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.